D-0291-2026 Class III Ongoing
FDA drug recall D-0291-2026 was initiated by Cipla USA, Inc. on Dec 22, 2025 and is designated Class III. Reason for recall: Failed PH Specifications The recall status is ongoing. Affected quantity: 92,376 tubes.
Recall Details
- Product Type
- Drugs
- Report Date
- Jan 28, 2026
- Initiation Date
- Dec 22, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 92,376 tubes
Product Description
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39
Reason for Recall
Failed PH Specifications
Distribution Pattern
Nationwide in the USA
Code Information
Batch XHBG; Exp. 08/31/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0291-2026
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026